FDA OKs Fibromyalgia Drug Savella

Savella Joins Cymbalta and Lyrica as Drugs Approved for Fibromyalgia Patients
By Miranda Hitti
WebMD Health News
Reviewed by Louise Chang, MD

Jan. 15, 2009 — The FDA has approved a new drug called Savella for the management of fibromyalgia.

Savella belongs to a class of drugs called serotonin and norepinephrine reuptake inhibitors (SNRIs), which include some antidepressants.

The drug companies behind Savella — Forest Laboratories Inc. and Cypress Bioscience Inc. — report that the FDA approved Savella based on two clinical trials that together included 2,084 fibromyalgia patients who took Savella or a placebo for three months or six months.

Savella trumped the placebo in the percentage of patients of who reported at least a 30% reduction in pain and also rated themselves as being “very much improved” or “much improved” in terms of their fibromyalgia, according to a joint news release from Forest Laboratories and Cypress Biosciences. More…